Congrats! Gilead Sciences (GILD) has just appointed Daniel O’Day as the Chief Executive Officer of the pharmaceutical giant.

After the markets closed Friday, MacroGenics (MGNX) announced a partial clinical hold on its Phase 1 monotherapy study of  MGD009, a bispecific antibody developed under …

Investing in the marijuana industry may have seemed taboo a few years back, but as more states are making recreational marijuana legal with …

Apple (AAPL) investors can breathe a (temporary) sigh of relief. Last week, US president Donald Trump and China president Xi Jinping agreed to …

Israeli generic drug manufacturer Teva (TEVA) was named by the Washington Post as being one of more than a dozen subjects of a …

Chinese consumer lending company Hexindai (HX) announced a strategic investment in what it only describes as a “target company” that is well-known in …

Marinus Pharmaceuticals (MRNS) just released positive results from its Phase 2 clinical trials, which evaluated ganaxolone intravenous (IV) (called the Magnolia Study) and …

Jeffries’ Philippe Houchois has met with Tesla’s (TSLA) management at the Fremont factory. The analyst called the tour of the plant “an interesting mix of …

At Credit Suisse 22nd Annual Technology conference, Micron (MU) warned investors revenue would be “near the low end” of their initial $7.9 billion to …

Investors don’t know what to think about Advanced Micro Devices (AMD). While the chip giant is up more than 70% for the year, …

Stifel’s top analyst Scott Devitt predicts Square (SQ) will deliver solid results for the fourth quarter and then bring the momentum into 2019 as well. …

Stifel’s top analyst Scott Devitt is calling out Facebook (FB) for being “unstable.” The analyst suggests Facebook’s management team has created a slew of …

While many investors are pulling out of Amazon (AMZN) stock, Tigress Financial’s Ivan Feinseth is going in. He sees this moment as an …

After a series of talks with depression key opinion leaders (KOL) about Acadia Pharmaceutical’s (ACAD) Ph2 CLARITY trial, all four experts believe the …

Will Amazon’s (AMZN) obsessive customer fan-base make room for another Amazon expedition? Last week, the tech company announced “Amazon Comprehend Medical,” a HIPAA-eligible …

Stifel’s top analyst Scott Devitt predicts Square (SQ) will deliver solid results for the fourth quarter and then bring the momentum into 2019 as well. …

H.C.

By Richard Robinson The biggest difference between investors and traders is their holding periods. Traders typically hold a position from between a few …

By Ophir Gottlieb and Tiernan Ray Top Pick Roku (ROKU) beat earnings estimates for revenue, EPS, active accounts, gross margins, and raised estimates …

Aerie Pharmaceuticals (AERI) has a new bull. Esther Rajavelu of Oppenheimer initiates coverage of the biotech with an Outperform rating and a $64 …

J.P Morgan’s Chris Schott recently met with Bausch Health (BHC) management to talk about the future of the pharmaceutical company.

Optical device and component manufacturer Applied Optoelectronics (AAOI) has suffered tremendous choppiness over the past two years. The dramatic shift in sentiment came from …

What does it take to have Facebook (FB) remove an account? Do you have to be a sexual harasser?

Can you feel the ground moving beneath your feet? Shares of Netflix (NFLX) skyrocket nearly 10% in pre-market trading Wednesday after the streaming …

Last night, the SEC charged Elon Musk, CEO and Chairman of Tesla (TSLA), with making a “series of false and/or misleading statements” regarding …